Post navigation
- Translating trial results into interpretable risk estimates: systematic analysis of cardiorenal outcome trials of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors
- Advancing type 2 diabetes therapy with iGlarLixi in older people: Pooled analysis of four randomized controlled trials


